Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis

Phase 4 Withdrawn Second Affiliated Hospital, School of Medicine, Zhejiang University

Non-randomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to determine whether Urinary Kallikrein has an additional effect on enhancing collateral circulation in symptomatic intracranial atherosclerotic patients under clopidogrel and aspirin dual antiplatelet therapy.

Timeline

Start: 2016-01
Primary completion: 2019-05
Completion: 2019-07

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Urinary Kallikrein	Unknown	0.15 iu	—

Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis

Summary

Timeline

Drugs

Indications